The decreased activation of the secrete form of MMP-2 might appear controversial as the literature mostly reported its overexpression during DCM, indicative of ECM degradation, interstitial collagen deposition, and consequent promotion of the fibrosis development [40]. The gene discussed is MMP2; the disease is familial dilated cardiomyopathy.